Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-10-03

Clinical Trial Update: Transitioning Open Heart Surgery Patients From Insulin Infusions to Detemir [Phase 4]

View source ↗

Summary

Phase 4 trial results examine switching open-heart surgery patients from insulin infusions to insulin detemir (Levemir).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (insulin)
  • Levemir (insulin detemir)

Snippet

Sponsor: Ohio State University | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2011-10-03